In the advent of targeted therapy in ovarian cancer, BRCA gene & “BRCA-ness” genes play a pivotal role in identifying the right patient for the right treatment. In this talk, we will details on the Who why when & how of BRCA testing as well as looking into the horizon of genes beyond BRCA such as HRR & HRD which can benefit a patient with ovarian cancer.